Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
KUNIMINE INDUSTRIES, Oct-Dec (3Q) Ordinary Profit Increases by 24%
5388 KUNIMINE INDUSTRIES CO.,LTD 【J-GAAP】
Earnings ReportKUNIMINE INDUSTRIES CO.,LTD <5388> [TSE Std] announced its financial results after the market closed on January 31st (15:30). The consolidated ordinary profit for the cumulative third quarter of the fiscal year ending March 2025 (April to December) was 1.14 billion yen, a 0.3% decrease compared to the same period last year. The progress rate toward the full-year plan of 1.56 billion yen was 73.2%, almost the same as the five-year average of 72.3%.
Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the January to March period (4Q) is expected to decrease 16.2% from the same period last year to 0.41 billion yen.
In the most recent three-month period, from October to December (3Q), the consolidated ordinary profit grew 23.6% from the same period last year, reaching 0.56 billion yen. However, the operating profit margin decreased from 10.0% in the same period last year to 9.3%.
Kabutan News
Actual Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Apr - Dec, 2022 | 11,358 | 496 | 997 | 586 | 45.9 | 72.6 | Jan 31, 2023 | J-GAAP |
Apr - Dec, 2023 | 11,669 | 839 | 1,145 | 779 | 62.5 | 69.6 | Jan 26, 2024 | J-GAAP |
Apr - Dec, 2024 | 11,494 | 847 | 1,142 | 753 | 61.5 | 73.2 | Jan 31, 2025 | J-GAAP |
YoY | -1.5% | +1.0% | -0.3% | -3.3% | -1.5% |
Current Period Guidance
Second Half Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Mar, 2023 | 8,278 | 821 | 953 | 571 | 45.8 | 25 | May 10, 2024 | J-GAAP |
Oct - Mar, 2024 Guidance | 8,936 | 919 | 979 | 663 | 54.4 | 25 | Oct 31, 2024 | J-GAAP |
YoY | +7.9% | +11.9% | +2.7% | +16.1% | +18.9% |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar, 2023 | 15,325 | 828 | 1,373 | 842 | 66.2 | 40 | May 12, 2023 | J-GAAP |
Mar, 2024 | 15,675 | 1,231 | 1,644 | 1,043 | 83.6 | 40 | May 10, 2024 | J-GAAP |
Mar, 2025 Guidance | 16,300 | 1,380 | 1,560 | 1,037 | 85.2 | 40 | May 10, 2024 | J-GAAP |
YoY | +4.0% | +12.1% | -5.1% | -0.6% | +1.8% |
Quarterly Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Dec, 2023 | 4,272 | 429 | 454 | 307 | 24.6 | 10.0 | Jan 26, 2024 | J-GAAP |
Jan - Mar, 2024 | 4,006 | 392 | 499 | 264 | 21.2 | 9.8 | May 10, 2024 | J-GAAP |
Apr - Jun, 2024 | 3,652 | 196 | 314 | 182 | 14.8 | 5.4 | Jul 31, 2024 | J-GAAP |
Jul - Sep, 2024 | 3,712 | 265 | 267 | 192 | 15.7 | 7.1 | Oct 31, 2024 | J-GAAP |
Oct - Dec, 2024 | 4,130 | 386 | 561 | 379 | 31.0 | 9.3 | Jan 31, 2025 | J-GAAP |
YoY | -3.3% | -10.0% | +23.6% | +23.5% | +25.8% |
Related Articles
BELLUNA, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 26%, Oct-Dec Ordinary Profit Increases by 75%
Kawagishi Bridge Works, Oct-Dec (1Q) Ordinary Profit Decreases by 13%
WELLNET, First Half Ordinary Profit Increases by 45%, Oct-Dec Ordinary Profit Increases by 29%
TOHO SYSTEM SCIENCE, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 6%
Temairazu, First Half Ordinary Profit Increases by 9%, Oct-Dec Ordinary Profit Increases by 11%
Tokyo Kiraboshi Financial, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 13%, Oct-Dec Ordinary Profit Increases by 31%
MEIDENSHA, The Current Fiscal Year Ordinary Profit Revised Upward by 19%, Raises Record High Profit Forecast
Sumitomo Pharma, The Current Fiscal Year Net Income Turns to Profit, Exceeds Expectations
TDSE, The Current Fiscal Year Ordinary Profit Revised Upward by 35%
NSK, Apr-Dec (Cumulative 3Q) Net Income Decreases by 17%, Oct-Dec Net Income Decreases by 52%